|
PTGES3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.985100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.366300E-04 |
| Normal-vs-Stage2 |
2.334200E-02 |
| Normal-vs-Stage3 |
5.97439999999727E-05 |
| Normal-vs-Stage4 |
3.70140000000019E-05 |
| Stage1-vs-Stage2 |
9.552400E-01 |
| Stage1-vs-Stage3 |
2.935400E-01 |
| Stage1-vs-Stage4 |
1.375830E-01 |
| Stage2-vs-Stage3 |
4.936600E-01 |
| Stage2-vs-Stage4 |
3.359400E-01 |
| Stage3-vs-Stage4 |
6.710400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.802900E-04 |
| Normal-vs-AfricanAmerican |
1.193830E-01 |
| Normal-vs-Asian |
2.895700E-03 |
| Caucasian-vs-AfricanAmerican |
3.846200E-01 |
| Caucasian-vs-Asian |
9.073000E-01 |
| AfricanAmerican-vs-Asian |
3.735000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4123000000027E-05 |
| Normal-vs-Female |
2.158300E-04 |
| Male-vs-Female |
1.973640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.442750E-03 |
| Normal-vs-Age(41-60Yrs) |
3.600800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.75022999999719E-05 |
| Normal-vs-Age(81-100Yrs) |
4.414000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.759000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.160850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.931800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.956640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.954000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.332800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.492000E-02 |
| Classical-VS-Follicular |
6.164900E-03 |
| Classical-VS-Other |
4.791000E-01 |
| Classical-VS-Normal |
5.100700E-03 |
| Tall-VS-Follicular |
6.853400E-01 |
| Tall-VS-Other |
9.432400E-01 |
| Tall-VS-Normal |
1.351010E-04 |
| Follicular-VS-Other |
9.397000E-01 |
| Follicular-VS-Normal |
2.09749999999786E-05 |
| Other-VS-Normal |
1.748230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.24619999999299E-05 |
| Normal-vs-N1 |
3.42010000320414E-08 |
| N0-vs-N1 |
7.260600E-03 |
|
|
